202 related articles for article (PubMed ID: 23102249)
1. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
Wu S; Cheng Z; Yu L; Song W; Tao Y
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Gal-3 and CD82/KAI1 proteins in non-small cell lung cancer and their clinical significance].
Wu SW; Yu L; Zhou L; Cheng ZN; Tao YS
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):124-8. PubMed ID: 23714667
[TBL] [Abstract][Full Text] [Related]
5. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
[TBL] [Abstract][Full Text] [Related]
7. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry.
Ci H; Xu Z; Xu J; Wang Y; Wu S
Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593
[TBL] [Abstract][Full Text] [Related]
8. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
9. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
10. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
[TBL] [Abstract][Full Text] [Related]
14. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
15. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
16. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
Guo C; Liu QG; Zhang L; Song T; Yang X
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
[TBL] [Abstract][Full Text] [Related]
18. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
[TBL] [Abstract][Full Text] [Related]
20. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
